Deltec Asset Management »

Esperion Therapeutics shares owned by Deltec Asset Management

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Deltec Asset Management from 13F filings

Historical chart of Deltec Asset Management investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Deltec Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Deltec Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $797k 252k 3.16

More positions owned by Deltec Asset Management

Alphabet Inc - CL A Cap Stk Cl A (GOOGL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Doordash Inc Cl A Cl A (DASH)
Ocular Therapeutix (OCUL)
Microsoft Corporation (MSFT)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Carnival Corp Ltd Common Share Common Shares (CCL)
Flex Ord (FLEX)
Visa Inc - Class A Shares Com Cl A (V)
Alaska Air (ALK)
Capital One Financial (COF)
Meta Platforms Inc Cl A Cl A (META)
Uber Technologies (UBER)

View all positions for Deltec Asset Management

Top funds holding Esperion Therapeutics

BlackRock
Two Seas Capital
Trium Capital
OrbiMed Advisors
Vanguard Capital Management
Two Sigma Investments
Marshall Wace
State Street Corporation
D. E. Shaw & Co
Geode Capital Management
AIGH Capital Management
UBS Group
Armistice Capital
PenderFund Capital Management
Nuveen

View all funds holding Esperion Therapeutics